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The reduced folate carrier (RFC), a facilitative transporter, plays a major role in the delivery of reduced folates and antifolates into cells.
Previous studies indicated that mutations of E45K in the first transmembrane domain (TMD), and K404L in the 11th TMD, produce selective
and opposite alterations in binding of natural folate substrates to murine RFC. The former mutation is frequently associated with antifolate
resistance. The current study was designed to determine whether there might be an interaction between these sites by comparing the transport
properties of RFC-null cell lines stably transfected with K404E, E45K, or E45K/K404E carriers. These studies demonstrated that: (1) All
mutant carriers were inserted into the plasma membrane. (2) In the K404E mutant, the influx Kt’s for 5-formyltetrahydrofolate and 5-
methyltetrahydrofolate were markedly increased, and to a much smaller extent folic acid, as compared to L1210 cells. However, with
introduction of a second E45K mutation the influx Kt for these folates reverted to those of the E45K cells which retained wild-type binding
for 5-methyltetrahydrofolate and enhanced binding of 5-formyltetrahydrofolate and folic acid. (3) The influx Vmax of the E45K mutant was
markedly reduced. Introduction of the second K404E mutation doubled this parameter and the ratio of Vmax to Kt for 5-formytetrahydrofolate
was restored to f 50% that of the wild-type carrier consistent with a substantial increase in function. (4) Chloride inhibits wild-type RFC but
the E45K mutant requires chloride for activity. The K404E mutant is also suppressed by chloride but introduction of the K404E mutation
decreased the chloride-dependence of E45K. The results suggest that there is an interaction between the E45 and K404 residues in the first
and 11th TMDs, respectively, but that the E45 residue appears to be the more dominant determinant of binding and anion sensitivity.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Residue; Folate; Carrier
1. Introduction that appears to be linked to organic anions concentrated with-The reduced folate carrier (RFC-SLC19A1) is a member
of the Major Facilitator Superfamily [1] and the major
transporter for 5-CH3-THF, the folate present in the plasma
of man and rodents [2]. RFC is essential for mouse develop-
ment and its deletion by homologous recombination results in
early embryonic lethality [3]. RFC is also the major route for
the delivery of antifolates into tumor cells and an important
determinant of the efficacy of these agents [4]. RFC generates
uphill transport of folates through an exchange mechanism0005-2736/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0005-2736(03)00136-6
Abbreviations: 5-CH3-THF, 5-methyltetrahydrofolate; 5-CHO-THF, 5-
formyltetrahydrofolate; HBS, HEPES buffered saline; MTX, methotrexate;
RFC, the reduced folate carrier; TMD, transmembrane domain
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E-mail address: igoldman@aecom.yu.edu (I.D. Goldman).in cells [5,6]. From a structural perspective, murine RFC is
predicted to have 12 transmembrane domains (TMDs), with
its N and C termini oriented to the cytoplasm; a similar
topology had been proposed for the human carrier [7,8].
However, recently, an alternative topology for TMD 9–12 of
human RFC was presented based upon hemagglutinin epi-
tope and scanning glycosylation insertion mutagenesis [9].
There has been considerable interest in identifying RFC
residues that are important determinants of function and
binding specificity. The first TMD has emerged as an
important site; in particular residues 45, 46, and 48 in
mRFC [10–12]. An E45K substitution in the murine and
human carriers with antifolate selective pressure, noted by
several groups, resulted in markedly decreased carrier
mobility, a change in the spectrum of substrate specifities
(decreased affinity for methotrexate (MTX), increased af-
finity for folic acid and 5-CHO-THF), and an obligatoryed.
R. Zhao et al. / Biochimica et Biophysica Acta 1613 (2003) 49–5650requirement for inorganic anions unlike the wild-type carrier
that is markedly inhibited by a variety of inorganic and
organic anions [10,13,14]. Systematic substitution of gluta-
mate-45 of murine RFC with other amino acids further
characterized the properties of this residue that are important
to carrier function [15].
Other charged residues in RFC TMDs also play an
important role in carrier function. Substitution of arginine-
131, -155, or -336 with leucine, by site-directed mutagen-
esis, abolished RFC activity. However, replacement of K404
with leucine in the 11th TMD maintained affinity for MTX
but markedly reduced affinity for 5-CHO-THF and 5-CH3-
THF and decreased the inhibitory effects of chloride on
RFC function [16]. Replacement of lysine-411 in human
RFC (corresponding to lysine-404 in murine RFC) with
arginine, glutamate, or leucine also decreased RFC function
although E411R was as active as the wild-type carrier in
transporting 5-CHO-THF [17].
Because glutamate-45 and lysine-404 are oppositely
charged and appear to play important but largely opposite
roles in determining the specificity of folate binding and
anion sensitivity, studies were undertaken to assess whether
there might be an interaction between these residues that
determines the configuration of the folate binding site, its
anion sensitivity, and/or whether one of these sites might
play a dominant role in these processes. This paper eval-
uates these possibilities by describing the properties of
mutant carriers in which residues were substituted either
with the oppositely charged species, E45K, K404E, or both
mutations—E45K/K404E. The results suggest that there is
an interaction between these residues in the first and 11th
TMDs but the E45 residue appears to be the dominant
determinant of binding and anion sensitivity.2. Materials and methods
2.1. Chemicals
[3V, 5V, 7-3H]-(6S)-5-CHO-THF was obtained from Mor-
avek Biochemicals (Brea, CA), and [3V, 5V, 7-3H]-MTX was
purchased from Amersham Corp. (Arlington Heights, IL).
Unlabeled MTX and 5-CHO-THF were provided by Lederle
(Carolina, Puerto Rico) while folic acid and 5-CH3-THF
were purchased from Sigma (St. Louise, MO). Both tritiated
and unlabeled compounds were purified by high perfor-
mance liquid chromatography before use [18]. All other
reagents were of the highest purity available from various
commercial sources.
2.2. Cell culture conditions and cell lines
A variety of L1210 murine leukemia cell lines were
utilized in these studies. These include: (i) the MTXrA
subline with an A130P mutation that markedly impaired
RFC function [19]; (ii) the D10 subline without RFC proteinbecause of a mutation in the ATG start codon [20,21]; (iii)
the R16 subline, an RFC-transfectant derived from MTXrA
that has high-level carrier expression [22]. The E45 cells
were previously reported [10], K404E and E45K/K404
mutant lines are described below. All cells were grown in
RPMI-1640 medium containing 2.3 AM folic acid, supple-
mented with 5% bovine calf serum (HyClone), 2 mM
glutamine, 20 AM 2-mercaptoethanol, penicillin (100
units/ml), and streptomycin (100 Ag/ml) at 37 jC in a
humidified atmosphere of 5% CO2. Transfectants were
cultured in the same medium supplemented with 750 Ag/
ml of G418.
2.3. Site-directed mutagenesis of RFC
Site-directed mutagenesis was carried out according to
the QuickChange protocol from Strategene as reported
previously [15]. For constructing K404E and E45K/
K404E expression vectors, RFC-pCDNA 3.1 and RFC-
E45K-pCDNA 3.1 were used as templates, respectively
[10]. A pair of complementary oligonucleotides (5V-
CTACTGCGCTTGAGACCTGTAACTC-3Vand 5V-GTGA-
TACAGGTCTCAAGCGCAGTAG-3V), which contains an
altered codon for position-404 (K404E), was used as the
primers in this protocol. The targeting vectors obtained
(RFC-K404E-pcDNA3.1 and RFC-E45K/K404E-
pcDNA3.1) were sequenced in the Albert Einstein Cancer
Center DNA Sequencing Facility. They harbor only the
targeted mutations. Large amounts of plasmid DNA used for
transfections were prepared using Wizard Plus Midipreps
(Promega).
2.4. Transfections
MTXrA (1107 cells) were electroporated (300 V, 200
AF) with 50 Ag of nonlinearized pcDNA3.1 (+) containing
the mutated RFC cDNA in a final volume of 800 Al of
serum-free RPMI-1640 medium. Cells were then diluted in
20 ml of complete RPMI-1640 medium, allowed to recover
for 48 h, adjusted to 2 105 cells/ml in medium containing
G418 (750 Ag/ml active drug), and then distributed into 96-
well plates at approximately 4 104 cells/well. Seventeen
and nine G418-resistant clones were obtained for K404E
and E45K/K404E construct transfections, respectively. One
K404E transfectant and one E45K/K404E transfectant were
selected for further studies because these two cell lines
demonstrated the highest level of MTX influx activity in
each group. The transfectants were maintained in RPMI-
1640 medium containing 750 Ag/ml G418.
2.5. Northern blot analysis
Total RNA was isolated from the transfectants, MTXrA,
and L1210 cells using the TRIzol reagent (Invitrogen). RNA
(20 Ag) was resolved by electrophoresis on 1% agarose gels
containing formaldehyde. The RNA was transferred to
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cross-linked to the membrane by a Stratalinker (Stratagene),
and hybridized first with murine RFC cDNA and then, after
stripping, with actin cDNA. The radioactive blots were
exposed to X-ray films overnight. Transcripts of both RFC
and actin were also quantitated by PhosphorImager analysis
to determine RFC message levels in the transfectants
relative to L1210 cells.
2.6. Western blot analysis
A polyclonal antibody, AE390, to the distal C terminus
of murine RFC (Met499 through Ala512) was used to probe
cell plasma membranes as reported [21]. Plasma membranes
were isolated by sucrose gradient ultracentrifugation using a
protease inhibitor cocktail (P8340, Sigma) at a dilution of
1:1000 instead of 1 mM phenylmethylsulfonylfluoride [23].
Protein concentrations of the total lysate and plasma mem-
branes were determined with the BCA Protein Assay Kit
(Pierce). The proteins were dissolved in a SDS-PAGE
loading buffer (60 mM Tris, 10% glycerol (v/v), 2% SDS
and trace bromophenol, pH 6.8) without heating and re-
solved on a 12% SDS-polyacrylamide gel. The proteins
were transferred to PVDF Transfer Membranes and pro-
cessed by the ECL Plus Western Blotting Detection System,
both obtained from Amersham Life Science.
2.7. Immunofluorescence
Cells were harvested, washed with PBS buffer, and then
fixed in 4% paraformaldehyde in PBS for 30 min at room
temperature. Cells were then washed twice with PBS buffer
and the cell pellets embedded in optimal cutting temperature
compound (OCT) for frozen sections. For staining, sections
were washed twice with PBS and incubated in 10% normal
goat serum for 30 min at room temperature. After removing
excess serum, the affinity purified AE390 antibody directed
to the murine RFC C terminus [21] was added to the sections
at a 1:50 dilution followed by incubation for 60 min at 4 jC.
The sections were then washed in PBS at 4 jC overnight
before incubation with fluorescein isothiocyanate (FITC)-
conjugated anti-rabbit-IgG (Invitrogen) at a 1:500 dilution
for 45 min at 4 jC. The sections were then washed five times
with PBS buffer and mounted with ProLong Antifade
solution (Molecular Probes). Photographs were obtained
under fluorescence microscopy with a 40-fold magnification.
2.8. Transport assay
Influx measurements were performed by methods de-
scribed previously [10] with minor modifications, in HEPES
buffered saline (HBS) (20 mM HEPES, 140 mM NaCl, 5
mM KCl, 2 mM MgCl2, 5 mM glucose, pH 7.4), HEPES-
sucrose-MgO buffer (20 mM HEPES, 235 mM sucrose, pH
7.4 with MgO), or mixtures of both. Briefly, cells were
harvested, washed twice with, and resuspended in, theappropriate buffer to a density of 1.5 107 cells/ml. Cell
suspensions were incubated at 37 jC for 25 min, following
which uptake was initiated by the addition of radiolabeled
folate and samples taken at the indicated times. Uptake was
terminated by injection of 1 ml of the cell suspension into
10 ml of ice-cold HBS. Cells were collected by centrifuga-
tion, washed twice with ice-cold HBS, and processed for
measurement of intracellular radioactivity [22]. For influx
determinations, uptake intervals were adjusted so that cell
MTX did not exceed the DHFR binding capacity assuring
that unidirectional uptake conditions were sustained. 5-
CHO-THF initial rates were established over an interval in
which cell folate uptake was linear as a function of time
with an extrapolated ordinate intercept at time zero near the
point of origin. 5-CHO-THF influx Kt and Vmax were
obtained from nonlinear regression of influx versus concen-
tration according to the Michealis–Menten equation. Influx
Ki’s for MTX, 5-CH3-THF, and folic acid were determined
by Dixon-plot analysis based upon inhibition of 5-CHO-
THF influx by these folate substrates in E45K, E45K/
K404E, and L1210 cells. These parameters were assessed
in K404E cells based upon inhibition of MTX influx by
these folate substrates. The higher influx of MTX as
compared to 5-CHO-THF in this cell line allowed more
accurate transport measurements for this RFC substrate.3. Results
3.1. Transfection and expression of the E45K, K404E, and
E45K/K404E mutant RFC carriers in the folate transport-
deficient MTXrA line
cDNAs of mutated carriers E45K, K404E, and E45K/
K404E were cloned into the mammalian expression vector
pcDNA 3.1 and transfected into MTXrA cells that lack
endogenous RFC function [19]. Several clones were
obtained for each transfection. The K404E and E45K/
K404E transfected clones that demonstrated the highest
MTX influx activities were chosen for further study and
named K404E and E45K/K404E cells, respectively. Prop-
erties of the E45K transfectant (E45K cells) were previously
reported [10].
Fig. 1A is a representative Northern blot of total RNA
from K404E and E45K/K404E cells along with wild-type
L1210 and recipient MTXrA cells. The message derived
from the expression vector in the transfectants was smaller
than, but could not be separated from, endogenous transcript
in MTXrA and L1210 cells. To determine the relative RFC
mRNA levels, Northern blots were quantitated by Phos-
phoImager analysis, normalized to actin levels, and then to
the mRFC level in L1210 cells that was assigned a value of
1. mRNA contributed by endogenous RFC in recipient
MTXrA cells was subtracted from the levels in transfectants.
RFC mRNA in the K404E and E45K/K404E cells was
comparable to the level in L1210 cells with the former only
Fig. 2. Detection of RFC proteins by fluorescence microscopy. Cells were harveste
with an antibody directed to the C terminus of murine RFC and then with FTIC-co
represent a 40-fold magnification.
Fig. 1. (A) Northern blot analysis of total RFC RNA and (B) Western blot
analysis of RFC protein in plasma membranes. (A) Total RNA was
hybridized successively with the full-length RFC and h-actin cDNA. The
data shown is a representative X-ray film. The level of transcripts was also
quantitated by PhosphorImager analysis of radioactive blots and normalized
to the levels of h-actin mRNA. The values indicated are the average of two
such analyses with a difference of less than 10% for K404E and E45K/
K404E cells. (B) Plasma membrane fractions isolated from transfectants
were probed with antibody directed to the C-terminus of the RFC. The
amount of plasma membrane loaded on the SDS-gel is indicated. Signals on
the X-ray film were determined by Kodak Image Station 440. Signal
changes in R16 cells as a function of RFC protein loaded were used to
quantitate RFC expression levels in the other cells. The RFC expression
levels relative to L1210 cells are indicated. The data are the average of two
separate experiments with a difference of less than 30%.
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cells than that in L1210 cells [10].
RFC protein in plasma membranes was assessed by
Western blot analysis (Fig. 1B). To account for discrep-
ancies in protein loading, different amounts of plasma
membranes from R16 cells, in which RFC is overexpressed,
were loaded in the same gel to serve as standards. In
addition, amounts of plasma membranes from different cell
lines loaded on the SDS-gel were adjusted in an attempt to
minimize differences in the RFC signals. Consistent with
the activity previously reported, R16 cells express f 9-fold
greater RFC protein than L1210 cells [22]. RFC protein in
MTXrA was 1/6 the level of L1210 cells. RFC proteins in
K404E and E45K/K404E were both about 1/2 the level of
L1210 cells; E45K was 30% greater than L1210 cells.
Hence, the ratio of RFC protein to RFC mRNA in all the
transfectants is less than in L1210 cells.
Expression of RFC was also monitored in transfectants
by immunofluorescence. As indicated in Fig. 2, no fluores-
cence was detected in D10 cells which completely lack RFC
protein [20,21]. These cells served as a negative control. In
MTXrA cells, the recipient of the transfections, there was
weak fluorescence that was not present in the plasma
membrane. RFC was detected in wild-type L1210 cells
mainly in the plasma membrane and, to a lesser extent, in
the cytosol, but was predominant at the plasma membrane
of R16 cells that overexpress wild-type RFC protein.
Fluoresence in the E45K, K404E, and E45K/K404E cells
was largely present at the plasma membrane although there
was some cytosolic fluorescence as well; strong staining
was found in only a portion of transfectants. Hence, like
wild-type and R16 cells, the mutated carriers appearedd, fixed and embedded in frozen sections. The sections were first incubated
njugated anti-rabbit-IgG as described in Materials and Methods. The images
Table 1
Comparison of 5-CHO-THF influx kinetic parameters in transfectants and
L1210 cells
Kt Vmax Vmax* Vmax* /Kt
L1210 5.4F 0.3 17.0F 1.6 17 3.2
E45K 1.5F 0.1 1.4F 0.1 1.1 0.73
E45K/K404E 1.5F 0.2 1.2F 0.1 2.2 1.5
K404E 55F 5 (Ki) 5.2 (calculated) 11 0.20
5-CHO-THF influx at substrate concentrations of 0.5, 1, 2, 3 or 5 AM was
determined in E45K/K404E cells. Influx Kt (AM) and Vmax (nmol/g dry wt/
min) for E45K/K404E cells were obtained from nonlinear regression to the
Michealis–Menten equation. These parameters for L1210 and E45K cells
reported previously [10] were used for purpose of comparison. 5-CHO-THF
influx Ki in K404E cells was determined from a Dixon plot analysis based
upon inhibition of [3H]-MTX influx by nonlabeled 5-CHO-THF. The 5-
CHO-THF influx Vmax in K404E cells was calculated from the Michealis–
Menten equation based upon 5-CHO-THF influx at 1 AM and the
assumption that the 5-CHO-THF influx Kt is equal to influx Ki. Vmax*
indicates the values normalized to the relative RFC protein expression
levels shown in Fig. 1B. Data are the meanF S.E. from three separate
experiments.
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evidence for a trafficking defect.
3.2. Influx of MTX and 5-CHO-THF
MTX and 5-CHO-THF initial uptake rates normalized to
the level of RFC protein in the plasma membrane were
determined (Fig. 3A). In all transfectants, influx of MTX
and 5-CHO-THF was lower than in L1210 cells, but greater
than in MTXrA cells, indicating that all mutants retained
some function. As indicated in Fig. 3B, 5-CHO-THF influx
was decreased by a factor of 5 in E45K cells and by a factor
of 10 in K404E cells as compared to L1210 cells. However,
influx in the double mutant was greater than in either mutant
alone, twice the sum of the single mutants, and only 40%
less than that of L1210 cells. The pattern for MTX influx
was somewhat different. Influx in the E45K was 1/10 that of
L1210 cells, but transport in the K404E was twice as fast (1/
5 that of L1210 cells), a pattern that was the reverse of what
was observed for 5-CHO-THF. Restoration of MTX trans-
port in the double mutant was less than that for 5-CHO-
THF. Hence, function was substantially restored for bothFig. 3. Comparison of influx of [3H]-MTX and [3H]-5-CHO-THF. After 25-
min incubation in HBS buffer at 37 jC, uptake was initiated by addition to
the cell suspension of 1 AM [3H]-MTX or [3H]-5-CHO-THF and terminated
by injecting 1 ml of the cell suspension into 9 ml of ice cold HBS. Influx is
the slope of uptake as a function of time measured within 2 min for MTX
and 1 min for 5-CHO-THF. (A) Initial uptake is normalized to the relative
RFC expression levels indicated in Fig. 1B except for MTXrA cells. (B)
Initial uptake is further normalized to the percentage of wild-type L1210
cells indicated as 100%. Data are the averageF S.E. from three separate
experiments.folates when carrier harbored both mutations although the
magnitude of restoration was greater for 5-CHO-THF.
3.3. Influx kinetics
Folate influx kinetics was determined to quantitate the
impact of the mutations on carrier affinities for the different
folates and the mobilities of the RFC-folate complexes. As
indicated in Table 1, the 5-CHO-THF influx Kt was de-
creased by a factor of f 3.6 in the E45K as reported
previously [10] and the influx Ki was increased by a factor
of 10 in the K404E mutant compared to the fourfold
increase in K404L [16]. However, the Kt reverted to that
of the E45K in the double mutant. The 5-CHO-THF influx
Vmax was normalized to the level of RFC in the plasma
membranes of these cell lines. There was a marked reduc-
tion (15-fold) in the Vmax for the E45K mutant. The Vmax for
the double mutant was twice that of the E45K but still far
less than that of wild-type L1210 cells. Finally, while Vmax/
Kt was decreased by factors of 4.4 and 16 in the E45K and
K404E cells, respectively, this value was restored to f 50%
of L1210 cells in the E45K/K404E cells consistent with
substantial preservation of function.
The influx Ki was also measured for MTX, 5-CH3-THF,
and folic acid based upon a Dixon analysis of inhibition of
5-CHO-THF influx in L1210, E45K, and E45K/K404E
cells or inhibition of MTX influx in K404E cells (the latter
measurement was made because of the higher influx of
MTX than 5-CHO-THF in this cell line) (Table 2). This
laboratory reported previously that the influx Ki for MTX
was markedly increased, and the influx Ki for folic acid was
marked decreased in E45K cells, while the influx Ki for 5-
CH3-THF was unchanged, as compared to the wild-type
RFC [10,15]. Influx Ki’s for MTX, 5-CH3-THF, and folic
acid in K404E cells were all increased as compared to
L1210 cells; the greatest increase (21-fold) was found for 5-
Fig. 4. Influx of [3H]-5-CHO-THF or [3H]-MTX as a function of chloride
concentration. Cells were harvested, washed with HEPES-sucrose-MgO
buffer twice and suspended with HBS, HEPES-sucrose-MgO buffer, or a
mixture of HBS and HEPES-sucrose-MgO buffer. The ratio of the two
buffers determined the final chloride concentration. After 25-min
incubation, influx was initiated by adding 1 AM [3H]-5-CHO-THF to
suspensions of L1210, E45K and E45K/K404E cells or 1 AM [3H]-MTX to
K404E cells. Influx is the slope of initial uptake as function of time within a
linear range. (A) Influx is normalized to the relative RFC expression levels
indicated in Fig. 1B. (B) Influx is normalized to the maximal level of
activity in each cell line. Influx in the absence of chloride for L1210 and
K404E, or influx at the highest chloride concentration for E45K and E45K/
K404E cells, was the maximal activity. Data are the meanF S.E. from three
separate experiments.
Table 2
Influx inhibition constants for MTX, 5-CH3-THF and folic acid
MTX 5-CH3-THF Folic acid
Ki D Ki D Ki D
L1210 4.4a 1 1.5b 1 240a 1
E45K 30b 6.8 1.3b 0.86 34a 0.14
K404E 39 8.7 31 21 605 2.5
E45K/K404 23 5.2 1.4 0.93 38 0.15
Ki (AM) in L1210, E45K and E45K/K404E cells was determined from
Dixon plot analyses based upon inhibition of [3H]-5-CHO-THF influx by
MTX, 5-CH3-THF and folic acid. Ki (AM) in K404E cells was determined
from the Dixon plot analyses based upon inhibition of [3H]-MTX influx by
nonlabeled MTX, 5-CH3-THF or folic acid. The data are the average of two
separate experiments.
D: Ratio of influx Ki in transfectants to L1210 cells.
a From Ref. [10].
b From Ref. [15].
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80% that of E45K cells, whereas influx Ki’s for 5-CH3-THF
and folic acid were virtually the same as in E45K cells and
far less than that in wild-type L1210 cells. Hence, for all of
these folate substrates, influx kinetics approximated the
E45K phenotype in the double mutants.
3.4. Effects of chloride on folate influx
One consequence of the E45K mutation was the intro-
duction of an obligatory anion requirement for carrier
function [10]. 5-CHO-THF influx in E45K cells was in-
creased with increasing concentration of chloride, in con-
trast to L1210 cells in which 5-CHO-THF influx decreased
as extracellular chloride concentration was increased (Fig.
4). As observed for L1210 cells, MTX influx in K404E cells
decreased with increasing concentration of chloride. How-
ever, the initial drop was steeper as the chloride concentra-
tion was increased from 0 to 14 mM. 5-CHO-THF influx in
E45K/K404E cells was stimulated as chloride concentration
was increased, similar to what was observed for the E45K
cells, but two differences were observed. (i) The percentage
of maximum for 5-CHO-THF influx in chloride-free buffer
for the double mutant was about twice that observed for the
E45K cells (Fig. 3B). (ii) 5-CHO-THF influx in E45K/
K404E cells reached its maximum at 25 mM chloride and
remained constant thereafter, whereas 5-CHO-THF influx in
E45K cells gradually increased as the chloride concentration
increased to 110 mM.
3.5. Impact of chloride on RFC affinity for 5-CHO-THF
To further characterize the impact of alterations in
extracellular chloride on transport mediated by the mutated
carriers, 5-CHO-THF influx kinetic parameters in these cell
lines were determined in HBS versus the chloride-free
HEPES-sucrose-MgO buffer. As summarized in Table 3,
in the absence of chloride the 5-CHO-THF influx Ki in
L1210 cells was decreased by a factor of f 3, consistentwith the concept that chloride is a competitive inhibitor of
folate binding to RFC [24]. In the absence of extracellular
chloride, the 5-CHO-THF influx Ki in K404E cells was
decreased by a factor of f 6, an even greater reduction than
in L1210 cells and consistent with the steep drop in MTX
influx as chloride concentration was increased (Fig. 4). This
suggests that the affinity of the K404E carrier for chloride
may be greater than that of the wild-type carrier. On the
other hand, the 5-CHO-THF influx Kt in E45K/E404E cells
was the same in the presence and absence of chloride and
was similar to what was observed for E45K cells. This
indicated that the decline in influx in both lines was due to a
fall in Vmax as the chloride concentration was decreased. In
the absence of chloride, the 5-CHO-THF influx Vmax in
E45K cells was decreased by a factor of 5.7, whereas the
influx Vmax in E45K/K404E cells was decreased by a factor
of only 2. Hence, while the Vmax for both carriers is
Table 3






L1210 Ki 5.6 1.6 3.5
E45K Kt 1.5F 0.1 1.9F 0.2 0.8
Vmax 1.42F 0.07 0.26F 0.03 5.5
K404E Ki 55F 5 9.7F 2.2 5.7
E45K/K404E Kt 1.5F 0.2 1.5F 0.3 1.0
Vmax 1.2F 0.1 0.61F 0.06 2.0
5-CHO-THF influx Ki (AM) was determined from Dixon plot analyses
based upon inhibition of [3]-MTX influx by 5-CHO-THF in L1210 and
K404E cells. 5-CHO-THF influx Kt (AM) and Vmax (nmol/g dry wt/min)
were determined by nonlinear regression of influx versus concentration
according to the Michealis–Menten equation. The Kt and Vmax values
determined in HBS (Table 1) were listed again for comparison. Data are the
meanF S.E. from three separate experiments except the Ki in L1210 cells,
which is the average of two experiments with a difference of less than 15%.
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E45K mutant appears to be greater.Fig. 5. Depiction of a possible interaction between E45 in the first TMD
and K404 in the 11th TMD of RFC. The membrane topology of murine
RFC is illustrated as predicted by Dixon et al. [31]. According this model,
E45 and K404 residues, depicted by circles, are located within the first and
11th TMDs, respectively, in proximity to the extracellular interphase.4. Discussion
A previous study demonstrated that 5-CHO-THF influx
was lower in cells with an E45K RFC mutation than in wild-
type L1210 cells despite an increased affinity of the E45K
mutant for 5-CHO-THF. This was attributed to a 12-fold
decrease in the 5-CHO-THF influx Vmax [10]. However, it
was not clear whether the decreased Vmax was the result of
decreased E45K protein expression or decreased mobility of
the RFC/5-CHO-5-THF complex. With the availability of
polyclonal antibodies against murine RFC [21], protein
expression levels in plasma membranes could now be
assessed by Western blot analysis and fluorescence micros-
copy. The amount of E45K mutant protein in plasma
membranes of E45K cells was only 30% greater than in
wild-type RFC in plasma membranes of L1210 cells despite
the fact that the RFC mRNA level in E45K cells was 4.5-
fold greater than that in L1210 cells, suggesting that the
mutation resulted in impaired translation, protein folding,
and/or stability. It does not appear that the difference
between mRNA and protein levels is due to impaired
trafficking and insertion into the plasma membrane since
E45K carrier is localized primarily to the plasma membrane.
Hence, the decrease in Vmax in E45K cells is likely due to
decreased mobility of the RFC-5-CHO-THF complex. This
decrease in carrier mobility could result from the introduc-
tion of a charge repulsion or attraction in the mutated carrier.
The further decrease in carrier mobility in the absence of
small anions, such as chloride, could be due to an alteration
in the interaction between the mutated residue and another
charged amino acid that increases in buffer with low ion
strength and is suppressed by small anions [10,15].
Detailed characterization of murine RFC mutations iden-
tified in antifolate-resistant cells has given insight into RFCdomains that are critical to binding of folates. For example,
E45K [10], S46N [11], and I48F [12] substitutions selec-
tively alter the affinity for different folates and/or the
mobility of carrier-folate complexes. Hence, the first
TMD, in which these three mutations are closely located,
is one important determinant of folate transport. In addition
to the first TMD, other TMDs have also been shown to play
important roles in folate binding/translocation. For instance,
a W105G mutation in the third TMD selectively increased
affinity for folic acid [12], while an S309F mutation in the
eighth TMD selectively decreased both affinity for MTX
and the mobility of the loaded carrier [25]. An S287N
mutation in the extracellular loop between the seventh and
eighth TMD decreased the affinity for MTX [26]. A K404L
mutation in the 11th TMD generated by site-directed muta-
genesis selectively, and markedly, decreased affinity for 5-
CHO-THF and 5-CH3-THF [16]. Substitution of K411 in
human RFC, corresponding to K404 in murine RFC, by
leucine, glutamate, and arginine also altered substrate spec-
ificity and carrier mobility [17]. Most recently, R373 of
human RFC in the 10th TMD was shown to be involved in
substrate translocation but not in substrate binding [27]. The
current study demonstrates that the K404E mutation in
murine RFC also selectively alters influx activity for
MTX and 5-CHO-THF. Hence, MTX influx mediated by
the K404E mutant was slightly greater than 5-CHO-THF
influx, while MTX influx mediated by wild-type RFC was
half that of 5-CHO-THF influx (Fig. 3). Taken together
these observations illustrate the multiple TMDs that play a
role in RFC binding and translocation.
Since crystal structures have not been achieved for
members of the Major Facilitator Superfamily of trans-
porters, site-directed mutants have been utilized to infer
structural relationships, best demonstrated for lactose per-
mease from Escherichia coli [28]. Identification of an
interaction between pairs of oppositely charged residues
localized in two different TMDs indicates that these TMDs
are closely packed together. For example, D237 and K358
in the lactose permease could be exchanged or simulta-
neously mutated to neutral residues without losing activity.
If only one of the two residues was replaced with a neutral
amino acid, the lactose permease was inactive [28]. Charge-
R. Zhao et al. / Biochimica et Biophysica Acta 1613 (2003) 49–5656paired residues were also identified in a vesicular mono-
amine transporter [29]. Recently, charged-paired resides
were identified in human RFC. Both the D88V in TMD 2
and K133L in TMD 4 mutants were not functional, but the
D88V/R133L construct was nearly as active as wild-type
human RFC [30].
In the current study, we examined a potential interaction
between the E45 and K404 residues, within the first and
11th TMDs, respectively, of murine RFC using a strategy in
which the charge of both residues was reversed. The data
suggest an interaction between these residues in the murine
carrier based upon three observations: (i) K404E had a
markedly decreased affinity for all folate substrates but
introduction of the second E45K mutation (in E45K/
K404E cells) restored the carrier affinity for 5-CHO-THF,
5-CH3-THF, and folic acid to the same level as that of the
E45K mutant. (ii) The E45K mutant carrier had markedly
reduced mobility; introduction of the second mutation
doubled the mobility of carrier and the ratio of Vmax to Kt
for 5-CHO-THF was restored to 1/2 that of wild-type
carrier. (iii) While chloride decreased wild-type RFC activ-
ity it increased activity of the E45K mutant. Like wild-type
cells, activity of the K404E mutant increased with a de-
crease in chloride; while the double mutant qualitatively was
similar to the E45K, the requirement for chloride was
substantially decreased.
Hence, while introduction of the double mutation sub-
stantially enhanced carrier function, in particular binding to
folate substrates, the overall phenotype of the E45K/K404E
carrier approximated that of the E45K mutant much more
than that of the K404E mutant or wild-type RFC. The
impact of the K404E mutation that results in a profound
loss in binding of the reduced folates, and to a lesser extent
folic acid, can be reversed by the introduction of the E45K
mutation in the same carrier molecule. The data therefore
suggest, as illustrated in Fig. 5, that the glutamate-45 residue
in the first TMD is in proximity to the lysine-404 residue in
the 11th TMD close to the membrane–extracellular inter-
face. The data indicate further that the lysine residue at
position 45 in the double mutant interacts more strongly
with folate substrates than the glutamate residue at position
404 and that the E45 residue is the dominant determinant of
folate binding although a variety of single substitutions at
the 45 position with amino acids other than lysine can
sustain function of the carrier [15].Acknowledgements
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